SÃO PAULO – Last week marked a historic milestone for the Brazilian medical community as Advanced Biomedical Concept and HPF Surgical officially introduced the Exashape systems to the nation’s leading surgical centers.
The launch was not merely a commercial entry but a high-level educational residency designed to establish a new gold standard in prepectoral breast reconstruction. Throughout the week, the mission focused on “clinical exchange,” bringing together European expertise and Brazil’s top surgical minds to master the unique properties of the Acellular Bovine Pericardium Membrane (ABPM).
A central pillar of the week was the intensive certification of the first three Brazilian Multiplicadores da Saúde: Dr. Fabrício Brenelli, Dr. Fábio Bagnoli, and Dr. Alexandre Piassi Passos. These renowned experts are now spearheaded to lead the adoption of Exashape across Brazil, ensuring the technology is backed by local clinical leadership.
Joining the delegation was Prof. Pier Camillo Parodi (University of Udine), who provided a masterclass in the practical application of the bilayer bovine pericardium scaffold. His presentation of real-world clinical cases demonstrated how the technology optimizes patient outcomes by promoting rapid neoangiogenesis and reducing inflammatory responses.
Media Spotlight: Dr. Fábio Bagnoli on BandNews TV
Following the successful training week in São Paulo, the partnership between ABC and HPF Surgical gained national attention. During a featured segment on BandNews TV, Dr. Fábio Bagnoli – President of the Brazilian Society of Mastology and one of the project’s peer educators – shared his clinical perspective on why this technology is a turning point for patient care in Brazil.
From the interview, here is what the doctor had to say regarding the transition to ABPM technology and its economic impact:
On ABPM Technology
“Esta membrana especificamente… é biológica, ela é provinda do pericárdio bovino… uma película que envolve o coração. Através da introdução na paciente que é submetida à mastectomia, ela apresenta as vantagens que nós médicos buscamos para melhor tratar as pacientes.”
“This specific membrane… is biological, derived from bovine pericardium… a film that surrounds the heart. By introducing it to patients undergoing mastectomy, it offers the advantages we as doctors seek to better treat our patients.”
On Cost-Effectiveness (ROI)
“Temos que pensar se vamos realizar uma cirurgia que vai gerar um melhor resultado… menos complicações, menos necessidade de outras cirurgias. Se colocarmos na ponta do lápis, o custo se equilibra e muitas vezes fica mais barato do que passar por duas internações.”
“We have to consider if we are performing a surgery that will yield a better result… fewer complications, and less need for additional surgeries. If we do the math, the cost balances out and is often cheaper than undergoing two separate hospitalizations.”
Why Exashape™?
The “Prepectoral Revolution” discussed throughout the week centers on the unique bilayer structure of the membrane. Exashape™ a features:
- Optimal Biocompatibility: A “cell-friendly” decellularization protocol that maintains the 3D collagen structure.
- Reduced Biomass: Lowering the risk of seroma and complications related to heavy biological loads.
- B2B Efficiency: For procurement teams, the reduction in Intra-Operative Time provides a compelling ROI, making advanced reconstruction more accessible.
As Brazil adopts this “bilayer solution,” the future of prepectoral reconstruction looks lighter, faster, and more integrated than ever before.
All clinical claims regarding Exashape™ and its classification as an Acellular Bovine Pericardium Membrane (ABPM) are based on current regulatory approvals and international clinical literature. In Brazil, this device is registered with ANVISA and must be used exclusively by qualified healthcare professionals in accordance with the official Instructions for Use (IFU). Marketing and promotional activities comply with local regulatory standards for Class III medical devices.
